Research Paper Volume 14, Issue 23 pp 9715—9729
A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy
Figure 2. GO enrichment analysis of the survival-associated genes. (A) Top 10 GO enrichment terms of the survival-associated genes of the entire dataset; (B) Top 10 GO enrichment terms of the survival-associated genes of Stage II; (C) Top 10 GO enrichment terms of the survival-associated genes of Stage III; (D) Top 10 GO enrichment terms of the survival-associated genes of Stage IV.